A phase 3, multicenter, open-label, randomized study of Nab®-Paclitaxel plus Gemcitabine versus Gemcitabine alone as adjuvant therapy in subjects with surgically resected pancreatic adenocarcinoma
- Harris, Marion (Primary Chief Investigator (PCI))
Project: Research